Walden Group Healthcare M&A Blog

The Walden Group 2024 Medical Device Outsourcing Report

1/24/2024
The Walden Group is pleased to provide access to its 2024 Medical Device Outsourcing Developments report, which includes: Highlights from the 2024 JPM Healthcare Conference Key Outsourcing Trends Developments in Surgical Robotics, AI, 3D Printing and more. Notable CDMO and OEM Transactions And More Click...
Read More
The Walden Group Releases Q3 2023 Strategic Healthcare M&A Report

11/2/2023
The Walden Group is pleased to provide access to its Q3 2023 Strategic Healthcare M&A Report, which includes:  Q3 2023 Market Overview Noteworthy M&A Deals By Sector Top Deals > $100m in Transaction Value Announced or Closed in Q3 2023 Performance of Leading Healthcare Companies Analysis of...
Read More
The Walden Group Releases Q2 2023 Strategic Healthcare M&A Report

08/10/2023
The Walden Group is pleased to provide access to its Q2 2023 Strategic Healthcare M&A Report, which includes:  Q2 2023 Market Overview Noteworthy M&A Deals By Sector Top Deals > $100m in Transaction Value Announced or Closed in Q2 2023 Performance of Leading Healthcare Companies Analysis of...
Read More
The Walden Group Releases Q1 2023 Strategic Healthcare M&A Report

5/02/2023
The Walden Group is pleased to provide access to its Q1 2023 Strategic Healthcare M&A Report, which includes:  Q1 2023 Market Overview Noteworthy M&A Deals By Sector Top Deals > $100m in Transaction Value Announced or Closed in Q1 2023 Performance of Leading Healthcare Companies Analysis...
Read More
Werfen Group Buys Immucor for $2b

3/29/2023
Spain-based manufacturer and distributor of diagnostic instruments Werfen has acquired Immucor, a manufacturer of transfusion and transplant diagnostic devices. The acquisition adds platelet detection, diagnostic analyzers, blood monitoring and molecular testing products that help match patients and donors. Deal terms -- $2b. Keywords:...
Read More